V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024303 | 20010326 | null | 78.4 | Neo-adjuvant (N) | 2017-04-06 | 2017-04-14 | FEC + DOCETAXEL | 2 | N | 20085884 | FEC + DOCETAXEL |
| 20024304 | 20010327 | 1.55 | null | Adjuvant (A) | 2013-08-20 | 2013-09-01 | FEC + DOCETAXEL | N | N | 20085909 | FEC + DOCETAXEL |
| 20024305 | 20010327 | 1.59 | 76.2 | Adjuvant (A) | 2013-08-03 | 2013-08-15 | FEC + DOCETAXEL | N | N | 20085909 | FEC + DOCETAXEL |
| 20024306 | 20010328 | 1.65 | 50.2 | Adjuvant (A) | null | 2018-01-24 | FEC + DOCETAXEL | N | N | 20085913 | FEC + DOCETAXEL |
| 20024307 | 20010329 | 1.73 | 72 | Adjuvant (A) | 2014-08-13 | 2014-08-24 | FEC + DOCETAXEL | 2 | N | 20085914 | FEC + DOCETAXEL |
| 20024308 | 20010329 | 1.69 | 58 | Neo-adjuvant (N) | 2016-09-15 | 2016-09-24 | FEC + DOCETAXEL | 2 | N | 20085914 | FEC + DOCETAXEL |
| 20024309 | 20108457 | 1.49 | 58 | Adjuvant (A) | 2015-08-02 | 2015-08-08 | FEC + DOCETAXEL | 02 | N | 20085918 | FEC + DOCETAXEL |
| 20024310 | 20010330 | 1.7 | 72.8 | Not known (9) | 2014-04-15 | 2014-04-22 | FEC + DOCETAXEL | N | N | 20085919 | FEC + DOCETAXEL |
| 20024311 | 20010330 | 1.65 | 71.8 | Neo-adjuvant (N) | 2016-06-22 | 2016-06-22 | FEC + DOCETAXEL | N | N | 20085919 | FEC + DOCETAXEL |
| 20024312 | 20010331 | 1.56 | 69 | Neo-adjuvant (N) | 2014-06-22 | 2014-07-21 | FEC + DOCETAXEL | 99 | N | 20085925 | FEC + DOCETAXEL |
| 20024313 | 20010331 | 1.72 | 134 | Adjuvant (A) | 2013-12-12 | 2013-12-14 | FEC + DOCETAXEL | 02 | N | 20085925 | FEC + DOCETAXEL |
| 20024314 | 20010331 | 1.7 | 63 | Adjuvant (A) | 2017-05-11 | 2017-05-11 | FEC + DOCETAXEL | 02 | N | 20085925 | FEC + DOCETAXEL |
| 20024315 | 20010332 | 1.66 | 53.2 | Adjuvant (A) | 2018-02-19 | 2018-02-26 | FEC + DOCETAXEL | 2 | N | 20085937 | FEC + DOCETAXEL |
| 20024316 | 20070979 | 1.57 | 112 | Adjuvant (A) | 2013-04-10 | 2013-07-01 | FEC 100 + DOCETAXEL | 2 | null | 20085942 | FEC + DOCETAXEL |
| 20024317 | 20070979 | 1.6 | 56.8 | Adjuvant (A) | 2016-02-28 | 2016-03-16 | FEC + DOCETAXEL | 02 | N | 20085942 | FEC + DOCETAXEL |
| 20024318 | 20070979 | 1.68 | 51.5 | Adjuvant (A) | 2014-05-31 | 2014-06-09 | FEC + DOCETAXEL | 02 | null | 20085942 | FEC + DOCETAXEL |
| 20024319 | 20070979 | 1.6 | 75 | Adjuvant (A) | 2013-05-19 | 2013-05-22 | FEC + DOCETAXEL | 02 | N | 20085942 | FEC + DOCETAXEL |
| 20024320 | 20070979 | 1.62 | 96.3 | Adjuvant (A) | 2017-10-04 | 2017-10-04 | FEC + DOCETAXEL | 02 | null | 20085942 | FEC + DOCETAXEL |
| 20024321 | 20070979 | 1.68 | 74 | Neo-adjuvant (N) | 2017-02-11 | 2017-02-17 | FEC + DOCETAXEL | 02 | N | 20085942 | FEC + DOCETAXEL |
| 20024322 | 20147332 | null | null | Adjuvant (A) | 2016-04-02 | 2016-04-02 | FEC + DOCETAXEL | N | N | 20085972 | FEC + DOCETAXEL |
| 20024323 | 20010333 | 1.57 | 92.8 | Neo-adjuvant (N) | 2013-12-24 | 2013-12-24 | FEC 100 + DOCETAXEL | 02 | N | 20085973 | FEC + DOCETAXEL |
| 20024324 | 20010333 | 1.63 | 53.7 | Neo-adjuvant (N) | 2017-05-07 | 2017-05-18 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20085973 | FEC + DOCETAXEL |
| 20024325 | 20010334 | 1.74 | 50.2 | Adjuvant (A) | 2017-03-29 | 2017-04-02 | FEC + DOCETAXEL | 02 | null | 20085985 | FEC + DOCETAXEL |
| 20024326 | 20010335 | null | null | Neo-adjuvant (N) | 2017-12-02 | 2018-01-01 | FEC + DOCETAXEL | N | null | 20085988 | FEC + DOCETAXEL |
| 20024327 | 20010335 | 1.72 | 69.5 | Neo-adjuvant (N) | 2016-08-24 | 2016-09-07 | FEC + DOCETAXEL | 02 | N | 20085988 | FEC + DOCETAXEL |
| 20024328 | 20010336 | null | null | Adjuvant (A) | 2013-03-14 | 2013-03-21 | FEC + DOCETAXEL | N | N | 20086001 | FEC + DOCETAXEL |
| 20024329 | 20010336 | 1.65 | 87 | Adjuvant (A) | 2017-04-02 | 2017-04-03 | FEC + DOCETAXEL | 02 | N | 20086001 | FEC + DOCETAXEL |
| 20024330 | 20010337 | 1.62 | 66.3 | Disease modification (D) | 2017-05-29 | 2017-06-12 | FEC + DOCETAXEL | N | null | 20086003 | FEC + DOCETAXEL |
| 20024331 | 20010337 | 1.7 | 73 | Neo-adjuvant (N) | 2014-08-12 | 2014-08-19 | FEC 100 + DOCETAXEL | 02 | N | 20086003 | FEC + DOCETAXEL |
| 20024332 | 20010338 | 1.61 | 73.7 | Adjuvant (A) | 2016-12-07 | 2016-12-07 | FEC + DOCETAXEL | 2 | N | 20086010 | FEC + DOCETAXEL |
| 20024333 | 20010338 | 1.64 | 86.2 | Curative (C) | null | 2013-09-03 | FEC 100 + DOCETAXEL | N | N | 20086010 | FEC + DOCETAXEL |
| 20024334 | 20010338 | null | 65 | null | 2018-01-09 | 2018-01-23 | FEC 100 + DOCETAXEL | N | N | 20086010 | FEC + DOCETAXEL |
| 20024335 | 20010339 | 1.63 | null | Adjuvant (A) | 2015-09-30 | 2015-10-14 | FEC + DOCETAXEL | 2 | null | 20086019 | FEC + DOCETAXEL |
| 20024336 | 20010339 | 1.56 | 85.4 | Not known (9) | 2016-05-16 | 2016-05-20 | FEC + DOCETAXEL | 02 | N | 20086019 | FEC + DOCETAXEL |
| 20024337 | 20010340 | 1.63 | 53.7 | Adjuvant (A) | 2014-08-13 | 2014-08-14 | FEC + DOCETAXEL | N | N | 20086024 | FEC + DOCETAXEL |
| 20024338 | 20010341 | 1.69 | null | Adjuvant (A) | 2014-07-25 | 2014-08-10 | FEC + DOCETAXEL | N | N | 20086034 | FEC + DOCETAXEL |
| 20024339 | 20010342 | 1.55 | 75.6 | Adjuvant (A) | 2017-05-29 | 2017-05-29 | FEC + DOCETAXEL | 02 | null | 20086035 | FEC + DOCETAXEL |
| 20024340 | 20010342 | 1.56 | 70 | Adjuvant (A) | 2016-10-02 | 2016-12-16 | FEC + DOCETAXEL | N | N | 20086035 | FEC + DOCETAXEL |
| 20024341 | 20010343 | 1.65 | 73.75 | Adjuvant (A) | 2016-11-18 | 2016-11-30 | FEC + DOCETAXEL | null | null | 20086039 | FEC + DOCETAXEL |
| 20024342 | 20010344 | 1.65 | 165 | Adjuvant (A) | 2016-04-15 | 2016-05-03 | FEC + DOCETAXEL | 2 | null | 20086040 | FEC + DOCETAXEL |
| 20024343 | 20010344 | 1.53 | 75.6 | Adjuvant (A) | 2014-09-17 | 2014-10-01 | FEC + DOCETAXEL | N | N | 20086040 | FEC + DOCETAXEL |
| 20024344 | 20010345 | 1.53 | 76 | Not known (9) | 2016-05-12 | 2016-06-02 | FEC + DOCETAXEL | N | N | 20086045 | FEC + DOCETAXEL |
| 20024345 | 20010346 | 1.65 | 91.7 | Neo-adjuvant (N) | 2014-12-04 | 2014-12-10 | FEC + DOCETAXEL | 2 | N | 20086050 | FEC + DOCETAXEL |
| 20024346 | 20010346 | 1.67 | 96 | Adjuvant (A) | 2016-10-25 | 2016-11-13 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20086050 | FEC + DOCETAXEL |
| 20024347 | 20010347 | 1.58 | 98.4 | Curative (C) | null | 2013-07-21 | FEC 100 + DOCETAXEL | N | null | 20086054 | FEC + DOCETAXEL |
| 20024348 | 20010347 | 1.47 | 70 | Adjuvant (A) | 2017-11-24 | 2017-11-26 | FEC 100 + DOCETAXEL | 2 | N | 20086054 | FEC + DOCETAXEL |
| 20024349 | 20010348 | 1.75 | 57.05 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-08 | FEC 100 + DOCETAXEL | N | N | 20086056 | FEC + DOCETAXEL |
| 20024350 | 20010349 | 1.62 | 75.8 | Adjuvant (A) | 2013-12-25 | 2014-01-15 | FEC 100 + DOCETAXEL | N | N | 20086058 | FEC + DOCETAXEL |
| 20024351 | 20010350 | 1.64 | 91.5 | Adjuvant (A) | 2014-11-18 | 2014-11-19 | FEC + DOCETAXEL | 02 | N | 20086061 | FEC + DOCETAXEL |
| 20024352 | 20010351 | null | 65.5 | Neo-adjuvant (N) | 2016-05-21 | 2016-05-21 | FEC + DOCETAXEL | 2 | N | 20086066 | FEC + DOCETAXEL |